Efficacy and Tolerability of Lopinavir/Ritonavir- and Efavirenz-Based Initial Antiretroviral Therapy in HIV-1-Infected Patients in a Tertiary Care Hospital in Beijing, China

Background: Lopinavir/ritonavir (LPV/r) is a major antiretroviral treatment in China, but little is known about the performance of first-line LPV/r-based regimen in treatment-naïve patients with human immunodeficiency virus type 1 (HIV-1) infection. This study aims to assess the efficacy and adverse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Su, Bin, Wang, Yin, Zhou, Ruifeng, Jiang, Taiyi, Zhang, Hongwei, Li, Zaicun, Liu, An, Shao, Ying, Hua, Wei, Zhang, Tong, Wu, Hao, He, Shenghua, Dai, Lili, Sun, Lijun
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920196/
https://ncbi.nlm.nih.gov/pubmed/31920659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01472
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados